Literature DB >> 11349016

Conservation of outer membrane protein E among strains of Moraxella catarrhalis.

T F Murphy1, A L Brauer, N Yuskiw, E R McNamara, C Kirkham.   

Abstract

Outer membrane protein E (OMP E) is a 50-kDa protein of Moraxella catarrhalis which has several features that suggest that the protein may be an effective vaccine antigen. To assess the conservation of OMP E among strains of M. catarrhalis, 22 isolates were studied with eight monoclonal antibodies which recognize epitopes on different regions of the protein. Eighteen of 22 strains were reactive with all eight antibodies. The sequences of ompE from 16 strains of M. catarrhalis were determined, including the 4 strains which were nonreactive with selected monoclonal antibodies. Analysis of sequences indicate a high degree of conservation among strains, with sequence differences clustered in limited regions of the gene. To assess the stability of ompE during colonization of the human respiratory tract, the sequences of ompE of isolates collected from patients colonized with the same strain for 3 to 9 months were determined. The sequences remained unchanged. These results indicate that OMP E is highly conserved among strains of M. catarrhalis, and preliminary studies indicate that the gene which encodes OMP E remains stable during colonization of the human respiratory tract.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349016      PMCID: PMC98340          DOI: 10.1128/IAI.69.6.3576-3580.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Cell fusion.

Authors:  R H Kennett
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  DNA restriction patterns produced by pulsed-field gel electrophoresis in Moraxella catarrhalis isolated from different geographical areas.

Authors:  G Martinez; K Ahmed; C H Zheng; K Watanabe; K Oishi; T Nagatake
Journal:  Epidemiol Infect       Date:  1999-06       Impact factor: 2.451

3.  Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease.

Authors:  K Groeneveld; L van Alphen; C Voorter; P P Eijk; H M Jansen; H C Zanen
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

4.  Complement-resistant Moraxella catarrhalis forms a genetically distinct lineage within the species.

Authors:  C M Verduin; M Kools-Sijmons; J van der Plas; J Vlooswijk; M Tromp; H van Dijk; J Banks; H Verbrugh; A van Belkum
Journal:  FEMS Microbiol Lett       Date:  2000-03-01       Impact factor: 2.742

Review 5.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

6.  Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis.

Authors:  T F Murphy; L C Bartos
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

7.  Antigenic structure of outer membrane protein E of Moraxella catarrhalis and construction and characterization of mutants.

Authors:  T F Murphy; A L Brauer; N Yuskiw; T J Hiltke
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

8.  Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis.

Authors:  L C Bartos; T F Murphy
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

9.  Acute otitis media caused by Branhamella catarrhalis: biology and therapy.

Authors:  G F Van Hare; P A Shurin; C D Marchant; N A Cartelli; C E Johnson; D Fulton; S Carlin; C H Kim
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

10.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1987-07
View more
  8 in total

1.  Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen.

Authors:  Stefan P W de Vries; Sacha A F T van Hijum; Wolfgang Schueler; Kristian Riesbeck; John P Hays; Peter W M Hermans; Hester J Bootsma
Journal:  J Bacteriol       Date:  2010-05-07       Impact factor: 3.490

2.  Characterization of a novel porin protein from Moraxella catarrhalis and identification of an immunodominant surface loop.

Authors:  Donna M Easton; Adam Smith; Sara Gomez Gallego; A Ruth Foxwell; Allan W Cripps; Jennelle M Kyd
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

Review 3.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

4.  Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.

Authors:  Xinan Jiao; Takashi Hirano; Yingchun Hou; Xin-Xing Gu
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

5.  The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its N-terminal passenger domain.

Authors:  Serena L Lipski; Christine Akimana; Jennifer M Timpe; R Mark Wooten; Eric R Lafontaine
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

Review 6.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 7.  Molecular aspects of Moraxella catarrhalis pathogenesis.

Authors:  Stefan P W de Vries; Hester J Bootsma; John P Hays; Peter W M Hermans
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

8.  Identification of an outer membrane lipoprotein involved in nasopharyngeal colonization by Moraxella catarrhalis in an animal model.

Authors:  Wei Wang; Stephanie N Joslin; Christine Pybus; Amanda S Evans; Flora Lichaa; Chad A Brautigam; Eric J Hansen
Journal:  Infect Immun       Date:  2014-03-18       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.